1.3 - to - (2 - carboxychromon - 5 - yloxy) - propane - 2 - ol in combination with antihistamines and medicinal products containing salts of 1,3 bis (2 - carboxychromon - 5 - yloxy) - propane - 2 - ol as such

摘要

The medicament comprises either a salt of 1,3-bis(2-carboxychromon-5-yloxy)-2-propanol with a basic compound containing a six-membered nitrogenous heterocycle and manifesting H1 receptor-antagonist antihistaminic properties, or a mixture comprising (a) one or more compounds chosen from 1,3-bis(2-carboxychromon-5-yloxy)-2-propanol and its pharmaceutically acceptable salts and (b) one or more antihistaminics containing a six-membered nitrogenous heterocycle and manifesting H1 receptor-antagonist properties.